SURGICAL ONCOLOGY Why biopsying metastatic breast cancer should be routine

被引：14

作者：

Sharma, Anand ^{[1
]}

Crook, Tim ^{[1
]}

Thompson, Alastair ^{[2
]}

Palmieri, Carlo ^{[1
]}

机构：

[1] Univ London Imperial Coll Sci Technol & Med, Div Canc, Dept Surg & Canc, London W12 0NN, England

[2] Univ Dundee, Ninewells Hosp, Dundee DD1 9SY, Scotland

来源：

NATURE REVIEWS CLINICAL ONCOLOGY | 2010年 / 7卷 / 02期

关键词：

RECEPTOR; ESTROGEN; THERAPY;

D O I：

10.1038/nrclinonc.2009.222

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Currently, acquisition of tissue from presumed metastatic deposits in breast cancer is not routine. Instead therapeutic decisions in this setting are based on the features of the tumor at initial diagnosis. As biopsies are diagnostic and changes can occur between the primary and the secondary tumors, the routine biopsy of suspected metastatic deposits needs to be considered. Such biopsies will also be key to translational research, which will underpin future therapeutic advances.

引用

页码：71 / 74

页数：4

共 10 条

[1] Clinical application of the 70-gene profile: The MINDACT trial [J].

Cardoso, Fatima ;

Van't Veer, Laura ;

Rutgers, Emiel ;

Loi, Sherene ;

Mook, Stella ;

Piccart-Gebhart, Martine J. .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (05) :729-735

[2] Patterns of cancer incidence, mortality, and prevalence across five continents: Defining priorities to reduce cancer disparities in different geographic regions of the world [J].

Kamangar, Farin ;

Dores, Graca M. ;

Anderson, William F. .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (14) :2137-2150

[3] Loss of estrogen receptor in recurrent breast cancer is associated with poor response to endocrine therapy [J].

Kuukasjarvi, T ;

Kononen, J ;

Helin, H ;

Holli, K ;

Isola, J .

JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (09) :2584-2589

[4] ESTROGEN AND PROGESTERONE-RECEPTOR CONCORDANCE BETWEEN PRIMARY AND RECURRENT BREAST-CANCER [J].

LI, BDL ;

BYSKOSH, A ;

MOLTENI, A ;

DUDA, RB .

JOURNAL OF SURGICAL ONCOLOGY, 1994, 57 (02) :71-77

[5] Prognostic impact of discordance between triple-receptor measurements in primary and recurrent breast cancer [J].

Liedtke, C. ;

Broglio, K. ;

Moulder, S. ;

Hsu, L. ;

Kau, S. -W. ;

Symmans, W. F. ;

Albarracin, C. ;

Meric-Bernstam, F. ;

Woodward, W. ;

Theriault, R. L. ;

Kiesel, L. ;

Hortobagyi, G. N. ;

Pusztai, L. ;

Gonzalez-Angulo, A. M. .

ANNALS OF ONCOLOGY, 2009, 20 (12) :1953-1958

[6] Serum HER-2/neu conversion to positive at the time of disease progression in patients with breast carcinoma on hormone therapy [J].

Lipton, A ;

Leitzel, K ;

Ali, SM ;

Demers, L ;

Harvey, HA ;

Chaudri-Ross, HA ;

Evans, D ;

Lang, R ;

Hackl, W ;

Hamer, P ;

Carney, W .

CANCER, 2005, 104 (02) :257-263

[7] Does confirmatory tumor biopsy alter the management of breast cancer patients with distant metastases? [J].

Simmons, C. ;

Miller, N. ;

Geddie, W. ;

Gianfelice, D. ;

Oldfield, M. ;

Dranitsaris, G. ;

Clemons, M. J. .

ANNALS OF ONCOLOGY, 2009, 20 (09) :1499-1504

[8]

Sparano JA, 2008, J CLIN ONCOL, V26, P721, DOI 10.1200/JCO.2008.16.7528

[9]

Wang Bo, 2004, Ai Zheng, V23, P1710

[10] Molecular portraits and 70-gene prognosis signature are preserved throughout the metastatic process of breast cancer [J].

Weigelt, B ;

Hu, ZY ;

He, XP ;

Livasy, C ;

Carey, LA ;

Ewend, MG ;

Glas, AM ;

Perou, CM ;

van't Veer, LJ .

CANCER RESEARCH, 2005, 65 (20) :9155-9158

← 1 →